Key Stats for Live Nation Stock
- Current Price: $168.87
- Target Price (Mid): ~$292
- Street Target: ~$185 (mean) / ~$190 (median)
- Potential Total Return: ~73%
- Annualized: ~13% / year
- Earnings Reaction: +6.71% (May 5, 2026)
- Max Drawdown: -27.84% (November 24, 2025)
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Live Nation Entertainment (LYV) has spent most of 2026 at the center of one of the loudest antitrust battles in American business history, yet the stock sits at $168.87, up more than 16% year to date, comfortably ahead of the S&P 500. The jury verdict didn’t break the bull case. Now the question is what actually drives LYV from here.
On May 14, President and CFO Joe Berchtold presented at the MoffettNathanson Media, Internet and Communications Conference and made the clearest public case yet for why the operating business is running well ahead of what the legal headlines suggest. This article unpacks what he said, cross-referenced against the TIKR data.
The Cancellation Panic Has No Data Behind It
The loudest short-side narrative right now is “Blue Dot fever,” the claim that rising cancellations signal a demand slowdown. Berchtold dismissed it with specifics at MoffettNathanson.
“There is absolutely no data that supports any issues,” he said. “We sold double digits more tickets at this point.” Deferred revenue across concerts and ticketing, meaning cash already collected for future shows, is running more than 20% above last year. Sell-through rates across amphitheaters, arenas, and stadiums are matching or exceeding 2025 levels. His read: scalpers frustrated by tighter artist pricing are seeding cancellation fears to spook artists into loosening up.
The Q1 2026 numbers confirm it. Revenue came in at $3,793.03 million, a 5.40% beat against consensus per TIKR, and first-quarter EBITDA of $371 million topped the $337.53 million estimate by nearly 10%. The stock gained 6.71% on the reporting date of May 5. The GAAP EPS loss of $1.85 that alarmed some investors was almost entirely caused by a $450 million legal accrual tied to the antitrust settlement. The operating business had its best first quarter on record.
Post-earnings, Guggenheim raised its price target to $197 while maintaining its Buy rating, and JPMorgan raised its target to $180.
See historical and forward estimates for Live Nation stock (It’s free!) >>>
About the Growth Story
The more important part of Berchtold’s MoffettNathanson appearance was his description of where the next five years of growth actually come from. His answer is unambiguously global.
“Every day, it’s more and more global,” he said. “Music, going to concerts is truly universal.” Post-COVID, both the supply of touring artists and international fan demand have accelerated together. Latin American artists like Bad Bunny, Karol G, and Peso Plumas have opened markets that barely registered on Live Nation’s planning horizon a decade ago. K-pop is doing the same across Asia.
The segment data backs this up. Per TIKR, Live Nation’s Other Foreign revenue grew from $4.09 billion in fiscal 2023 to $5.06 billion in fiscal 2025. European segment revenue reached $5.82 billion in 2025, up from $4.43 billion in 2023. Berchtold said explicitly that the majority of fan growth over the next five years will come from outside the U.S., and the numbers already show it starting.
That global expansion runs through Venue Nation, Live Nation’s dedicated division targeting 48 new venues in five years and a $600 million adjusted operating income run rate by 2032. The 20% IRR threshold for venue investments is a floor, not a target. “We’ve been more likely to outperform than underperform,” Berchtold said. The portfolio combines ground-up builds in Madrid and Munich, acquisitions in Paris, and capital-light partnerships in Latin America, where construction is faster and cheaper.
The Financing Innovation That Barely Made Headlines
On May 8, Live Nation closed a €610 million venue-backed note financing, secured by real estate assets at four venues in the U.S., the Netherlands, and Ireland, raised at 5.5% through an investment-grade vehicle. Berchtold called it the first transaction of its kind in the live entertainment industry.
The structure separates venue real estate into its own collateral pool, allowing higher leverage and lower rates on the property side without burdening the operating company. The operating business stays in a 3x to 4x leverage range. The venue portfolio can carry more debt because it is backed by hard assets with recurring revenue streams. The result: a dedicated, lower-cost funding mechanism for the 48-venue buildout that does not compete with artist guarantees or working capital needs. For investors worried about capital discipline as venue spending accelerates, this structure directly answers the question.
The Legal Timeline in Plain Terms
A federal jury found Live Nation liable for monopolizing the live events industry on April 15, 2026. The judge, not the jury, determines remedies, and that process will not reach a hearing until at least February 2027. The next status conference is July 30, 2026.
Berchtold described the process as sequential: pending motions on expert testimony go first, then DOJ settlement review, then remedies. The DOJ settlement, agreed to in March, requires divesting 13 exclusive booking agreements, an eight-year extension of the consent decree, and a $280 million fund for state damages. The judge has publicly stated that the settlement is a sound framework.
The company has already booked the $450 million legal accrual in Q1. What remains unresolved is whether the remedies phase produces an outcome consistent with that framework or escalates toward structural separation of Ticketmaster from the concert and venue businesses. The former keeps the integrated economics intact. The latter is the bear case.
Competitor Context
On an NTM EV/EBITDA basis, Live Nation trades at 15.68x per TIKR. CTS Eventim (EVD), the dominant European live events and ticketing operator, trades at 6.45x. Vivid Seats (SEAT), the U.S. secondary ticketing marketplace, trades at 10.87x. Live Nation’s premium reflects its global scale and the antitrust uncertainty still embedded in the multiple. If the remedies process resolves without structural disruption, the case for that gap narrowing becomes more compelling.
See how Live Nation performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $168.87
- Target Price (Mid): ~$292
- Potential Total Return: ~73%
- Annualized: ~13% / year
See analysts’ growth forecasts and price targets for Live Nation stock (It’s free!) >>>
The TIKR mid case uses a revenue CAGR of around 7% from 2025 to 2030, driven by global fan growth and Venue Nation reaching operational maturity. TIKR consensus estimates show revenue growing from $25.2 billion in fiscal 2025 to approximately $27.8 billion in 2026 and $30.3 billion in 2027.
The margin driver is free cash flow normalization. FCF is estimated at approximately $1.3 billion in 2026, growing to around $2.7 billion by 2030 per TIKR, as Venue Nation preopening costs and litigation expenses fade. Net income margin, compressed to near breakeven in 2025 and 2026, is projected to recover toward around 2% by 2028 per the TIKR model.
The high case reaches approximately $444 by 12/31/30, assuming around 8% revenue growth and a faster premium hospitality ramp. The low case lands at approximately $264, reflecting slower growth at around 6% and prolonged legal friction. The primary risk in both scenarios is the remedies process: a structural Ticketmaster separation would disrupt the integrated economics the model is built around.
The Street mean target is approximately $185, and the median is approximately $190, per TIKR’s 25-analyst consensus of 17 Buys, 3 Outperforms, 3 Holds, 1 Underperform, and 1 Sell. The TIKR mid case implies materially more upside than the Street currently prices in.
Conclusion
The most important date on the LYV calendar before year-end is July 30, 2026, when the remedies status conference takes place. What the states file then will tell investors whether the process is tracking toward the DOJ framework the judge has already endorsed, or toward something more disruptive. A remedies outline consistent with the DOJ settlement would be the clearest signal yet that the legal discount embedded in LYV’s multiple is about to compress. Everything else, the global venue buildout, the international fan growth, and the securitization structure is already working.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Live Nation?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Live Nation, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Live Nation alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze Live Nation on TIKR Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
